Melanocortin-1 receptor-mediated signalling pathways activated by NDP-MSH and HBD3 ligands. [electronic resource]
Producer: 20120827Description: 370-4 p. digitalISSN:- 1755-148X
- Agouti Signaling Protein -- pharmacology
- Anticarcinogenic Agents -- pharmacology
- Cyclic AMP -- metabolism
- Dose-Response Relationship, Drug
- Drug Evaluation, Preclinical
- HEK293 Cells
- Humans
- Ligands
- MAP Kinase Signaling System -- drug effects
- Melanocytes -- drug effects
- Receptor, Melanocortin, Type 1 -- agonists
- Signal Transduction -- drug effects
- Up-Regulation -- drug effects
- alpha-MSH -- analogs & derivatives
- beta-Defensins -- agonists
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.